{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T06:57:43Z","timestamp":1770793063003,"version":"3.50.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.vaccine.2006.10.040","type":"journal-article","created":{"date-parts":[[2006,11,4]],"date-time":"2006-11-04T12:14:12Z","timestamp":1162642452000},"page":"1416-1425","source":"Crossref","is-referenced-by-count":54,"title":["Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909"],"prefix":"10.1016","volume":"25","author":[{"given":"Rezwanul","family":"Wahid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosangela","family":"Salerno-Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol O.","family":"Tacket","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron M.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo B.","family":"Sztein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.10.040_bib1","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2006.10.040_bib2","series-title":"New generation vaccines","first-page":"479","article-title":"Attenuated strains of Salmonella enterica serovar typhi as live oral vaccines against typhoid fever","author":"Levine","year":"2004"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2006.10.040_bib3","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1093\/clinids\/24.Supplement_1.S106","article-title":"Multidrug-resistant Salmonella typhi: a worldwide epidemic","volume":"24","author":"Rowe","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2006.10.040_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0264-410X(95)00186-5","article-title":"Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization","volume":"14","author":"Klugman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.10.040_bib5","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1128\/IAI.73.6.3521-3530.2005","article-title":"Immunization of volunteers with Salmonella enterica serovar Typhi strain Ty21a elicits the oligoclonal expansion of CD8+ T cells with predominant V\u03b2 repertoires","volume":"73","author":"Salerno-Goncalves","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.10.040_bib6","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.4049\/jimmunol.173.9.5852","article-title":"Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine","volume":"173","author":"Salerno-Goncalves","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.10.040_bib7","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.4049\/jimmunol.169.4.2196","article-title":"Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine","volume":"169","author":"Salerno-Goncalves","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.10.040_bib8","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1128\/IAI.67.3.1338-1346.1999","article-title":"Potent immunoregulatory effects of Salmonella typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells","volume":"67","author":"Wyant","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.10.040_bib9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/CDLI.10.3.426-430.2003","article-title":"T- and B-cell immune responses of patients who had undergone colectomies to oral administration of Salmonella enterica serovar Typhi Ty21a vaccine","volume":"10","author":"Kilhamn","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2006.10.040_bib10","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1128\/IAI.67.7.3680-3685.1999","article-title":"Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria","volume":"67","author":"Viret","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.10.040_bib11","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1128\/IAI.70.10.5622-5627.2002","article-title":"Oral immunization with a Salmonella enterica serovar typhi vaccine induces specific circulating mucosa-homing CD4(+) and CD8(+) T cells in humans","volume":"70","author":"Lundin","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.10.040_bib12","series-title":"Vaccines","first-page":"597","article-title":"Typhoid fever vaccines","author":"Levine","year":"1994"},{"key":"10.1016\/j.vaccine.2006.10.040_bib13","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/IAI.67.11.5806-5810.1999","article-title":"Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in vietnam","volume":"67","author":"Kossaczka","year":"1999","journal-title":"Infect Immun"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2006.10.040_bib14","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0264-410X(99)00231-5","article-title":"Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine","volume":"17","author":"Levine","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.10.040_bib15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/bmj.316.7125.110","article-title":"Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity","volume":"316","author":"Engels","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2006.10.040_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0168-1656(95)00094-1","article-title":"Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors","volume":"44","author":"Levine","year":"1996","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2006.10.040_bib17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1128\/IAI.65.2.452-456.1997","article-title":"Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans","volume":"65","author":"Tacket","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.10.040_bib18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/clim.2000.4924","article-title":"Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C","volume":"97","author":"Tacket","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2006.10.040_bib19","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.68.3.1196-1201.2000","article-title":"Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers","volume":"68","author":"Tacket","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.10.040_bib20","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.4049\/jimmunol.170.5.2734","article-title":"Concomitant Induction of CD4(+) and CD8(+) T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain CVD 908-htrA","volume":"170","author":"Salerno-Goncalves","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.10.040_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/421469","article-title":"Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide","volume":"190","author":"Tacket","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.10.040_bib22","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1128\/IAI.68.8.4647-4652.2000","article-title":"Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909","volume":"68","author":"Wang","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.10.040_bib23","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/infdis\/170.6.1508","article-title":"Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi","volume":"170","author":"Sztein","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.10.040_bib24","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.4049\/jimmunol.164.4.2221","article-title":"Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain","volume":"164","author":"Samandari","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.10.040_bib25","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.4049\/jimmunol.155.8.3987","article-title":"Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans","volume":"155","author":"Sztein","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.10.040_bib26","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1128\/IAI.67.7.3619-3624.1999","article-title":"Salmonella typhi flagella are potent inducers of proinflammatory cytokine secretion by human monocytes","volume":"67","author":"Wyant","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.10.040_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0022-1759(00)00191-5","article-title":"Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity","volume":"240","author":"Rininsland","year":"2000","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2006.10.040_bib28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.0105-2896.2006.00423.x","article-title":"Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation","volume":"212","author":"Izcue","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2006.10.040_bib29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0882-4010(92)90014-F","article-title":"Role of T cells, TNF alpha and IFN gamma in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro-Salmonella vaccines","volume":"13","author":"Mastroeni","year":"1992","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2006.10.040_bib30","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.4049\/jimmunol.147.9.3161","article-title":"The involvement of tumor necrosis factor in immunity to Salmonella infection","volume":"147","author":"Tite","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.10.040_bib31","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.4049\/jimmunol.145.12.4290","article-title":"Leishmania major amastigotes initiate the l-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha","volume":"145","author":"Green","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.10.040_bib32","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1128\/IAI.66.10.4767-4776.1998","article-title":"Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB\/c mice: role of gamma interferon and macrophage activation","volume":"66","author":"Mastroeni","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.10.040_bib33","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cell.2006.02.019","article-title":"Translating innate immunity into immunological memory: implications for vaccine development","volume":"124","author":"Pulendran","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2006.10.040_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0008-8749(85)90033-4","article-title":"Macrophage-mediated mitogenic suppression induced in mice of the C3H lineage by a vaccine strain of Salmonella typhimurium","volume":"91","author":"Lee","year":"1985","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2006.10.040_bib35","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.4049\/jimmunol.146.8.2737","article-title":"Immunosuppression induced by attenuated Salmonella. Evidence for mediation by macrophage precursors","volume":"146","author":"al Ramadi","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.10.040_bib36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0140-6736(90)92266-K","article-title":"Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial","volume":"336","author":"Levine","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.10.040_bib37","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/infdis\/159.4.766","article-title":"Comparative efficacy of two, three, or four doses of Ty21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area","volume":"159","author":"Ferreccio","year":"1989","journal-title":"JID"},{"key":"10.1016\/j.vaccine.2006.10.040_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0264-410X(90)90183-M","article-title":"Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial","volume":"8","author":"Black","year":"1990","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06011819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06011819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T17:12:09Z","timestamp":1683652329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06011819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0264410X06011819"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.10.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}